Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory Myopathy

By  

Current Rheumatology Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 157-165

Bentham Science Publishers

Access to resources Recommend Favorite

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

By Kolho Kaija-Leena   Sipponen Taina  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 4, 2014-04 ,pp. : 434-441

Informa Healthcare

Access to resources Recommend Favorite

Screening of tumor necrosis factor receptor-associated factor 6 as a candidate gene for inflammatory bowel disease

By Lappalainen Maarit   Paavola-Sakki Paulina   Halme Leena   Turunen Ulla   Heliö Tiina   Färkkilä Martti   Kontula Kimmo  

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 4, 2006-03 ,pp. : 424-429

Informa Healthcare

Access to resources Recommend Favorite

Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 32, Iss. 4, 2014-06 ,pp. : 446-454

Karger

Access to resources Recommend Favorite

Patient’s Perspectives Important for Early Anti-Tumor Necrosis Factor Treatment in Inflammatory Bowel Disease

By  

Digestion, Vol. 79, Iss. 1, 2009-02 ,pp. : 30-35

Karger

Access to resources Recommend Favorite